PUBLIC NOTICE ON FALSIFIED BATCH OF HERCEPTIN 440MG (TRASTUZUMAB 440MG)

The Pharmacy and Poisons Board (PPB) wishes to alert the public about a suspicious batch of falsified Herceptin 440mg (Trastuzumab 440mg) product that has been detected in the market. The product batch is CLAIMED to be manufactured in Germany by: Roche Products Ltd, bearing the Batch number C5830083, Mfg. Date: 12/2021, Exp. Date: 11/2024.
The public is notified that this specific product batch number C5830083 is a confirmed counterfeit. It is not authorized to be in the market and is a falsified product in view of the falsified contents, packaging and labelling aspects which have been confirmed by the brand owner.
Consequently, the PPB cautions the public against the use, supply, sale or distribution of the product batch number C5830083 as their safety, quality and efficacy CANNOT be assured.
Further, the PPB in collaboration with government investigative agencies has instituted legal and regulatory actions against individuals suspected to be perpetrating the illegal activities in contravention of the Pharmacy and Poisons Act (Cap. 244).
The PPB has initiated a rapid response and heightened surveillance of the market to ensure that safety and public health is protected. We would like to assure the public that PPB has established robust market surveillance and control system that continuously monitor the quality and safety of medical products in the Kenyan market.